Page last updated: 2024-08-23
zidovudine and Cerebral Infarction, Middle Cerebral Artery
zidovudine has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cai, HH; Chen, L; Ding, XS; Li, WL; Liu, N; Luo, CX; Wang, B; Zhou, QG; Zhu, DY | 1 |
Other Studies
1 other study(ies) available for zidovudine and Cerebral Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke.
Topics: Analysis of Variance; Animals; Antimetabolites; Bromodeoxyuridine; Cell Count; Cognition Disorders; Disease Models, Animal; Fluoxetine; Infarction, Middle Cerebral Artery; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neurogenesis; Neurons; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Space Perception; Swimming; Time Factors; Zidovudine | 2009 |